Records 1 - 4
| Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.
International immunopharmacology 2021 Oct 101 (Pt A): 108156.
Huang Yinde, Xie Zhenyu, Li Xin, Chen Wenbin, He Yuzhen, Wu Song, Li Xinyang, Hou Bingchen, Sun Jianjian, Wang Shiyue, He Yuchen, Jiang Han, Lun Yu, Zhang Ji
| HLA-G 3' untranslated region polymorphic sites associated with increased HLA-G production are more frequent in patients exhibiting differentiated thyroid tumours.
Clinical endocrinology 2016 Dec .
de Figueiredo-Feitosa Nathalie Lobo, Martelli Palomino Gustavo, Cilião Alves Daiani Cristina, Mendes Junior Celso Teixeira, Donadi Eduardo Antonio, Maciel Léa Maria Zani
| HLA-DR association in papillary thyroid carcinoma.
Disease markers 2010 28 (1): 49-53.
Amoli Mahsa M, Yazdani Nasrin, Amiri Parvin, Sayahzadeh Forogh, Haghpanah Vahid, Tavangar Seyed Mohammad, Amirzargar Ali, Ghaffari Hamidollah, Nikbin Behrooz, Larijani Bagher, Mostaan Leila V, Bazzaz Javad Tavakko
| Associations between HLA-C alleles and papillary thyroid carcinoma.
Cancer biomarkers : section A of Disease markers 2009 5 (1): 19-22.
Haghpanah Vahid, Khalooghi Keinoosh, Adabi Khadijeh, Amiri Parvin, Tavangar Seyed Mohammad, Amirzargar Ali, Ghaffari Hamidollah, Yazdani Nasrin, Nikbin Behrooz, Larijani Bagher, Amoli Mahsa